Shareholders' Equity - Schedule of Share-Based Incentive Plan Grant Activity (Details) - Options and SAR's $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) $ / shares shares
Shares
Outstanding, beginning balance (in shares) | shares	829,417
Granted (in shares) | shares	98,998
Exercised (in shares) | shares	(275,347)
Forfeited (in shares) | shares	(24,574)
Outstanding, ending balance (in shares) | shares	628,494
Exercisable, ending balance (in shares) | shares	443,632
Weighted Average Exercise Price
Beginning balance (in dollars per share) | $ / shares	$ 101.44
Granted (in dollars per share) | $ / shares	168.43
Exercised (in dollars per share) | $ / shares	85.85
Forfeited (in dollars per share) | $ / shares	151.93
Ending balance (in dollars per share) | $ / shares	116.90
Exercisable, end of period (in dollars per share) | $ / shares	$ 99.47
Outstanding weighted average remaining contractual terms (years)	6 years
Exercisable weighted average remaining contractual term (years)	5 years
Outstanding aggregate intrinsic value | $	$ 25.2
Exercisable aggregate intrinsic value | $	$ 24.7